Cargando…
The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis
INTRODUCTION: The clinical effect of pharmacotherapy on prostate morphometric parameters is largely unknown. The sole exception is 5α-reductase inhibitors (5-ARI) that reduce prostate volume and prostate-specific antigen (PSA). This review assesses the effect of pharmacotherapy on prostate parameter...
Autores principales: | Sakalis, Vasileios, Gkotsi, Anastasia, Charpidou, Dimitra, Tsafrakidis, Petros, Apostolidis, Apostolos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552938/ https://www.ncbi.nlm.nih.gov/pubmed/34729231 http://dx.doi.org/10.5173/ceju.2021.132.R1 |
Ejemplares similares
-
Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms
por: Sakalis, Vasileios, et al.
Publicado: (2021) -
A pure microcytic bladder carcinoma synchronous to prostatic adenocarcinoma
por: Sakalis, Vasileios, et al.
Publicado: (2011) -
Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer
por: Tolani, Musliu Adetola, et al.
Publicado: (2020) -
Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015) -
Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia
por: Hsiao, Chun-Jen, et al.
Publicado: (2016)